Valuation: EMVision Medical Devices Ltd

Market Cap 161M 115M 99.69M 94.22M 85.54M 160M 11.04B 1.12B 435M 5.6B 432M 423M 17.84B P/E 2027 *
-15.4x
P/E 2028 * -13.3x
Enterprise Value 161M 115M 99.69M 94.22M 85.54M 160M 11.04B 1.12B 435M 5.6B 432M 423M 17.84B EV / Sales 2027 *
32.3x
EV / Sales 2028 * 19x
Free-Float
66.77%
Yield 2027 *
-
Yield 2028 * -
1 day-5.19%
1 week-5.73%
Current month-3.80%
1 month-6.00%
3 months+7.17%
6 months+2.17%
Current year-7.58%
1 week 1.64
Extreme 1.645
1.74
1 month 1.64
Extreme 1.635
1.9
Current year 1.47
Extreme 1.47
1.96
1 year 1.47
Extreme 1.47
2.21
3 years 1.44
Extreme 1.445
2.72
5 years 1.13
Extreme 1.13
3.35
10 years 0.28
Extreme 0.28
4.2
Manager TitleAgeSince
Chief Executive Officer - 01/07/2023
Director of Finance/CFO - 01/02/2026
Chief Tech/Sci/R&D Officer - 01/07/2023
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - 01/07/2018
Date Insider Type Main position Quantity % Market Cap. Importance
23/4/26 Buy

Director

10,000 0.0108%
2/1/26 Expiration

Chairman

300,000 0.3228%
18/11/25 Free

Director

200,000 0.2176%
Change 5-day change 1-year change 3-year change Capi.($)
-5.19%-5.73%-19.76%0.00% 115M
+1.10%+7.06%+34.88%+25.78% 240B
-0.48%+1.71%+9.39%-18.37% 146B
+1.36%+8.22%-12.02%+29.35% 135B
+0.09%-2.34%-55.64%-16.99% 63.64B
+0.78%+0.44%-18.35%-14.76% 49.27B
+4.13%+3.60%+18.90%+21.97% 51.46B
+2.28%+6.18%+20.83%+32.59% 43.33B
+0.37%+3.42%+38.13%+51.79% 41.13B
+2.99%+11.67%+125.59%+56.64% 34.57B
Average +0.73%+2.49%+14.20%+16.80% 80.48B
Weighted average by Cap. +1.05%+4.32%+14.23%+15.25%

Financials

2027 *2028 *
Net sales 5M 3.57M 3.09M 2.92M 2.65M 4.97M 342M 34.87M 13.48M 174M 13.4M 13.1M 553M 8.5M 6.06M 5.25M 4.97M 4.51M 8.45M 582M 59.28M 22.91M 295M 22.77M 22.27M 940M
Net income -12M -8.56M -7.42M -7.01M -6.36M -11.93M -821M -83.69M -32.34M -416M -32.15M -31.44M -1.33B -14.5M -10.34M -8.96M -8.47M -7.69M -14.41M -992M -101M -39.08M -503M -38.85M -37.99M -1.6B
Net Debt - -
Logo EMVision Medical Devices Ltd
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
Employees
-
Date Price Change Volume
17/09/26 $1.645 -5.19% 7,346
16/09/26 $1.735 +0.58% 26,103
15/09/26 $1.725 +2.37% 28,134
14/09/26 $1.685 -3.44% 8,835
11/09/26 $1.745 0.00% 5,920
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.735AUD
Average target price
3.150AUD
Spread / Average Target
+81.56%

Annual profits - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!